CD44 promotes hepatocellular carcinoma progression via upregulation of YAP

Abstract Hepatocellular carcinoma (HCC) is a common malignancy in human. CD44 is a transmembrane glycoprotein which is frequently overexpressed in cancer of various origins. The function and mechanism of CD44 in HCC remains elusive. In this study, we reported that CD44 was overexpressed in HCC to pr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jun Zhang, Xilin He, Yajie Wan, Honghong Zhang, Tao Tang, Meng Zhang, Shiyi Yu, Weiyong Zhao, Liming Chen
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
YAP
Acceso en línea:https://doaj.org/article/a0f2cfa14d3a42d0b8233f2d622ff2b1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a0f2cfa14d3a42d0b8233f2d622ff2b1
record_format dspace
spelling oai:doaj.org-article:a0f2cfa14d3a42d0b8233f2d622ff2b12021-11-21T12:07:59ZCD44 promotes hepatocellular carcinoma progression via upregulation of YAP10.1186/s40164-021-00247-w2162-3619https://doaj.org/article/a0f2cfa14d3a42d0b8233f2d622ff2b12021-11-01T00:00:00Zhttps://doi.org/10.1186/s40164-021-00247-whttps://doaj.org/toc/2162-3619Abstract Hepatocellular carcinoma (HCC) is a common malignancy in human. CD44 is a transmembrane glycoprotein which is frequently overexpressed in cancer of various origins. The function and mechanism of CD44 in HCC remains elusive. In this study, we reported that CD44 was overexpressed in HCC to promote the proliferation and migration of HCC cells via oncogenic YAP, which is the key downstream regulator in Hippo pathway. These findings suggest that CD44-YAP is a probable important axis in pathogenesis of HCC, providing an insight in to HCC pathogenesis as well as potential targets for the intervention of HCC.Jun ZhangXilin HeYajie WanHonghong ZhangTao TangMeng ZhangShiyi YuWeiyong ZhaoLiming ChenBMCarticleHepatocellular carcinomaCD44YAPDiseases of the blood and blood-forming organsRC633-647.5Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENExperimental Hematology & Oncology, Vol 10, Iss 1, Pp 1-4 (2021)
institution DOAJ
collection DOAJ
language EN
topic Hepatocellular carcinoma
CD44
YAP
Diseases of the blood and blood-forming organs
RC633-647.5
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Hepatocellular carcinoma
CD44
YAP
Diseases of the blood and blood-forming organs
RC633-647.5
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Jun Zhang
Xilin He
Yajie Wan
Honghong Zhang
Tao Tang
Meng Zhang
Shiyi Yu
Weiyong Zhao
Liming Chen
CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
description Abstract Hepatocellular carcinoma (HCC) is a common malignancy in human. CD44 is a transmembrane glycoprotein which is frequently overexpressed in cancer of various origins. The function and mechanism of CD44 in HCC remains elusive. In this study, we reported that CD44 was overexpressed in HCC to promote the proliferation and migration of HCC cells via oncogenic YAP, which is the key downstream regulator in Hippo pathway. These findings suggest that CD44-YAP is a probable important axis in pathogenesis of HCC, providing an insight in to HCC pathogenesis as well as potential targets for the intervention of HCC.
format article
author Jun Zhang
Xilin He
Yajie Wan
Honghong Zhang
Tao Tang
Meng Zhang
Shiyi Yu
Weiyong Zhao
Liming Chen
author_facet Jun Zhang
Xilin He
Yajie Wan
Honghong Zhang
Tao Tang
Meng Zhang
Shiyi Yu
Weiyong Zhao
Liming Chen
author_sort Jun Zhang
title CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
title_short CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
title_full CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
title_fullStr CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
title_full_unstemmed CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
title_sort cd44 promotes hepatocellular carcinoma progression via upregulation of yap
publisher BMC
publishDate 2021
url https://doaj.org/article/a0f2cfa14d3a42d0b8233f2d622ff2b1
work_keys_str_mv AT junzhang cd44promoteshepatocellularcarcinomaprogressionviaupregulationofyap
AT xilinhe cd44promoteshepatocellularcarcinomaprogressionviaupregulationofyap
AT yajiewan cd44promoteshepatocellularcarcinomaprogressionviaupregulationofyap
AT honghongzhang cd44promoteshepatocellularcarcinomaprogressionviaupregulationofyap
AT taotang cd44promoteshepatocellularcarcinomaprogressionviaupregulationofyap
AT mengzhang cd44promoteshepatocellularcarcinomaprogressionviaupregulationofyap
AT shiyiyu cd44promoteshepatocellularcarcinomaprogressionviaupregulationofyap
AT weiyongzhao cd44promoteshepatocellularcarcinomaprogressionviaupregulationofyap
AT limingchen cd44promoteshepatocellularcarcinomaprogressionviaupregulationofyap
_version_ 1718419202961833984